Engaging vulnerable populations: Making the right connections for better health

A woman from a low-income neighborhood chooses not to receive care from her closest health center, which is located in

Read more

Report: Chronic conditions lead to medical debt at all income levels

Medical debt — which is often a result of the expensive ongoing treatment provided for chronic conditions — is the

Read more

Transitioning to a single-use mindset, getting ahead of the curve

The move towards single use scopes and other medical devices had its start long before Covid-19, but the pandemic has

Read more

CVS Health reports 15.7% reduction in suicide attempts among Aetna members

Newly released data by CVS Health showed that its new initiative reduced suicide attempts among Aetna members by 15.7% in

Read more

Seagen broadens its scope beyond ADC cancer drugs with deal for preclinical asset

Seagen, a specialist in a type of cancer therapy called an antibody drug conjugate (ADC), is expanding its reach with

Read more

When it comes to satisfaction, only a few major differences exist between MA and traditional Medicare

As the open enrollment period nears, many Medicare beneficiaries will be faced with the decision of choosing a traditional Medicare

Read more

Prime Medicine spells out IPO plans for ‘word processor’ of gene editing

Gene-editing research is striving for more precise approaches, aiming to avoid off-target edits that spark problems elsewhere in the genome.

Read more

The cancer death rate is falling — focusing on equity and personalization will help it drop further

Last week, the American Association for Cancer Research released its annual report on the progress of cancer care in the

Read more

How to stay at the forefront of healthcare innovation

Healthcare is an industry designed to provide essential services and care for patients to improve their health and well-being. Over

Read more

FDA advisory committee issues back to back negative votes on two cancer drugs

An independent committee that advises the FDA on cancer drugs has weighed in on medicines from Spectrum Pharmaceuticals and Oncopeptides,

Read more